NCT02753426View on ClinicalTrials.gov

A Trial of Doxycycline in Renal Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

January 31, 2018

Conditions
Chronic Kidney DiseaseCardiorenal Syndrome
Interventions
DRUG

Doxycycline

Doxycycline 20mg capsule by mouth, twice a day for 30 days.

DRUG

Placebo (for Doxycycline)

Inactive pill manufactured to mimic Doxycycline 20mg. Capsule by mouth, twice a for 30 days.

Trial Locations (1)

94110

Zuckerberg San Francisco General Hospital, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT02753426 - A Trial of Doxycycline in Renal Disease | Biotech Hunter | Biotech Hunter